Queen Mary University of London: New Drug Can Successfully Treat Patients Typically Resistant To High Blood Pressure Treatment
November 08, 2022
November 08, 2022
LONDON, England, Nov. 8 (TNSjou) -- Queen Mary University of London issued the following news:
A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial led jointly by a Queen Mary University of London researcher and colleagues at CinCor Pharma, USA.
Published in the New England Journal of Medicine and presented . . .
A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial led jointly by a Queen Mary University of London researcher and colleagues at CinCor Pharma, USA.
Published in the New England Journal of Medicine and presented . . .